IPCR News

Bridging the gap between cancer drug target and cancer drug

Bridging the gap between cancer drug target and cancer drug

Fred Hutch RNA-translation expert Dr. Andrew Hsieh receives Harrington Scholar-Innovator Award to develop experimental compound into anti-cancer drug
Hutch NewsMay 02, 2024
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow

BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow

In memory of runner Gabe Grunewald, research at Fred Hutch will inform new treatments for rare and aggressive cancers
Hutch NewsOctober 17, 2023
Improving immunotherapy for advanced prostate cancer

Improving immunotherapy for advanced prostate cancer

Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Hutch NewsApril 27, 2023
Tracking prostate cancer dynamics

Tracking prostate cancer dynamics

Single-cell study brings prostate tumors into focus and highlights potential treatment target: cancer complexity
Hutch NewsDecember 13, 2022
Award will fund research into new metastatic prostate cancer therapies

Award will fund research into new metastatic prostate cancer therapies

Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Hutch NewsOctober 21, 2022
Dr. Anat Zimmer receives AAUW fellowship

Dr. Anat Zimmer receives AAUW fellowship

Fred Hutch computational biologist who relocated from Israel will receive support while investigating cancer genomics
Hutch NewsOctober 13, 2022